Mirati Therapeutics, Inc.

Bank of New York Mellon Corp

Report date

12/31/2023

Quarter

2023 Q4

Filed

1/29/2024

Shares

1,010,099

Value ($000)

59,343

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	1/29/2024	59,343	0.0%	1,010,099	12/31/2023
2023 Q3	10/24/2023	8,394	0.0%	192,705	9/30/2023
2023 Q2	8/3/2023	6,625	0.0%	183,365	6/30/2023
2023 Q1	5/9/2023	6,330	0.0%	170,264	3/31/2023
2022 Q4	2/14/2023	7,655	0.0%	168,956	12/31/2022
2022 Q3	11/14/2022	12,238	0.0%	175,203	9/30/2022
2022 Q2	8/15/2022	43,118	0.0%	642,293	6/30/2022
2022 Q1	5/11/2022	13,014	0.0%	158,279	3/31/2022
2021 Q4	2/11/2022	24,684	0.0%	168,280	12/31/2021
2021 Q3	11/18/2021	28,374	0.0%	160,394	9/30/2021
2021 Q2	8/11/2021	29,482	0.0%	182,514	6/30/2021
2021 Q1	5/13/2021	27,322	0.0%	159,494	3/31/2021
2020 Q4	2/9/2021	42,510	0.0%	193,546	12/31/2020
2020 Q3	11/12/2020	25,865	0.0%	155,759	9/30/2020
2020 Q2	8/12/2020	16,966	0.0%	148,600	6/30/2020
2020 Q1	5/6/2020	9,548	0.0%	124,207	3/31/2020
2019 Q4	2/14/2020	16,025	0.0%	124,363	12/31/2019